The technology company Bending Spoons announced today that it has completed the acquisition of WeTransfer, the brand and platform for collaboration and file sharing founded in the Netherlands. About the acquisition To celebrate the acquisition
A group of investors led by Verium, a multi-family office advised by Advestra, has acquired a significant minority stake in Lynus through a capital increase. Lynus is
CMS advised Complementa on its sale to Zürcher Kantonalbank, advised by Niederer Kraft Frey (“NKF”). Complementa has been supporting Zürcher Kantonalbank (“ZKB”) with investment reporting services since 2006 and has become an important partner
Paolo Michele Patocchi (pictured), from Patocchi & Marzolini, has been appointed by ICC Switzerland as a member of the Swiss Commission of Arbitration and ADR and the Swiss Delegation to the ICC Commission on Arbitration
Twelve Capital, advised by Homburger, and Securis Investment Partners (“Securis”), two independent asset management specialists in Insurance-Linked Securities (“ILS”), announced their intention to merge, with both sets of shareholders remaining fully invested in the combined
Walder Wyss has advised Neustark, a Switzerland-based carbon removal provider, on a growth financing round in the amount of USD 69 million. The new capital will enable Neustark to continue its rapid scale-up in the carbon
Dentons announced that its Global Board of Directors and Global Advisory Committee have elected Kate Barton (pictured) as the Firm’s next Global CEO. Barton will join Dentons from EY, where
Clifford Chance announces record financial results for the fiscal year ended April 30, 2024 (May 2023/April 2024). The firm has recorded its highest revenue growth rate since 2017 and double-digit growth in partnership profit. The global teams handling litigation,
Niederer Kraft Frey (“NKF”) advised the management team led by Niklaus Hilti on the acquisition of Credit Suisse Insurance Linked Strategies (“CSILS”) from UBS. CSILS will operate independently from UBS under a new name and
Baker McKenzie advised KD Pharma Group, a global producer of pharmaceutical and nutritional lipids, on the acquisition of dsm-firmenich’s marine lipids business in exchange for a minority stake in KD Pharma Group. The transaction
